Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Welgus Howard G. sold 4,728 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 19, 2026
On Oct 15, 2026, Welgus Howard G. (Director) sold 4,728 Arcutis Biotherapeutics, Inc. shares at US$26.93 for US$127K under a trading plan, leaving 35,207 shares. Filed Oct 19, 2026 (Form 4).
- Sold
- 4,728 shares
- Price
- US$26.93
- Value
- US$127K
- Holding after
- 35,207 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | Option exercise | 822 | US$6.52 | 36,663 | Direct |
| Oct 15, 2026 | Common Stock | Option exercise | 1,018 | US$7.51 | 37,681 | Direct |
| Oct 15, 2026 | Common Stock | Option exercise | 2,254 | US$8.63 | 39,935 | Direct |
| Oct 15, 2026 | Common Stock | Sale | 4,728 | US$26.93 | 35,207 | Direct |
Source
Download original · View original at SEC
Related
- Arcutis Biotherapeutics, Inc.
- Welgus Howard G.
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Welgus Howard G. · Aug 19, 2026
- Form 4 · Welgus Howard G. · Jul 17, 2026
- Form 4 · Welgus Howard G. · Jun 17, 2026
- Form 4 · Welgus Howard G. · Jun 9, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026
- Form 4 · Curran Terrie · Aug 28, 2026
- Form 4 · Curran Terrie · Aug 24, 2026